Drug Discovery Services Market

Drug Discovery Services Market Analysis by Process (Target Selection, Target Validation, Hit-To-Lead Identification), by Type (Medicinal Chemistry, Biology Services, Pharmacokinetics), by Drug Type (Small Molecules and Biologics) by Therapeutic Area, by Region - Global Market Insights 2022 to 2032

Analysis of Drug Discovery Services market covering 30 + countries including analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan, Korea and many more

Drug Discovery Services Market
  • FACT375MR
  • 05 May 2022
  • Healthcare
  • 170 Pages
  • 173 Tables
  • 111 Figures

Table of Content

  • 1. Global Economic Outlook
  • 2. Global Market - Executive Summary
  • 3. Global Market Overview
  • 4. Global Market Analysis and Forecast 2015 to 2032
    • 4.1. Global Market Size and Forecast by Process, 2015 to 2032
      • 4.1.1. Target Selection
      • 4.1.2. Target Validation
      • 4.1.3. Hit-To-Lead Identification
      • 4.1.4. Lead Optimization
      • 4.1.5. Candidate Validation
    • 4.2. Global Market Size and Forecast By Type, 2015 to 2032
      • 4.2.1. Medicinal Chemistry
      • 4.2.2. Biology Services
      • 4.2.3. Drug Metabolism and Pharmacokinetics
    • 4.3. Global Market Size and Forecast By Drug Type, 2015 to 2032
      • 4.3.1. Small Molecules
      • 4.3.2. Biologics
    • 4.4. Global Market Size and Forecast By Therapeutic Area, 2015 to 2032
      • 4.4.1. Oncology
      • 4.4.2. Neurology
      • 4.4.3. Respiratory Diseases
      • 4.4.4. Cardiovascular Diseases
      • 4.4.5. Diabetes
      • 4.4.6. Other Therapeutic Areas
  • 5. North America Market Size and Forecast, 2015 to 2032
  • 6. Latin America Market Size and Forecast, 2015 to 2032
  • 7. Europe Market Size and Forecast, 2015 to 2032
  • 8. Japan Market Size and Forecast, 2015 to 2032
  • 9. APEJ Market Size and Forecast, 2015 to 2032
  • 10. MEA Market Size and Forecast, 2015 to 2032
  • 11. Global Market Company Share, Competition Landscape and Company Profiles
    • 11.1. Thermo Fisher Scientific, Inc.
    • 11.2. GE Healthcare
    • 11.3. Charles River Laboratories International
    • 11.4. Agilent Technologies, Inc.
    • 11.5. Eli Lilly and Company
    • 11.6. Lonza Group Ltd
    • 11.7. WuXi AppTec Co. Ltd.
    • 11.8. Evotec AG
    • 11.9. Pharmaceutical Product Development LLC
    • 11.10. Merck Millipore
    • 11.11. Albany Molecular Research, Inc.
    • 11.12. Covance Inc.
    • 11.13. Genscript Biotech Corporation
    • 11.14. Aurigene Discovery Technologies Limited
    • 11.15. Syngene International Limited
    • 11.16. Promega Corporation
    • 11.17. SRI International, Inc.
    • 11.18. Chembridge Corporation
    • 11.19. GVK Biosciences Private Limited
    • 11.20. Domainex Ltd.
    • 11.21. Selcia Limited
    • 11.22. Viva Biotech Ltd.
    • 11.23. Jubilant Biosys Limited
    • 11.24. Ubiquigent Limited
    • 11.25. ReproCELL, Inc.
    • 11.26. DiscoverX Corporation
    • 11.27. Creative Bioarray
  • 12. Research Methodology
  • 13. Secondary and Primary Sources
  • 14. Assumptions and Acronyms
  • 15. Disclaimer

List Of Table

TABLE 1 Global Market Value (US$ Mn), 2015 to 2021

TABLE 2 Global Market Value (US$ Mn), 2022 to 2032

TABLE 3 Global Market Value (US$ Mn) and Y-o-Y, 2022 to 2032

TABLE 4 Global Target Selection Segment Value (US$ Mn), By Region 2015 to 2021

TABLE 5 Global Target Selection Segment Value (US$ Mn), By Region 2022 to 2032

TABLE 6 Global Target Selection Segment Market Share, By Region 2015 to 2021

TABLE 7 Global Target Selection Segment Market Share, By Region 2022 to 2032

TABLE 8 Global Target Selection Segment Y-o-Y, By Region 2022 to 2032

TABLE 9 Global Target Validation Segment Value (US$ Mn), By Region 2015 to 2021

TABLE 10 Global Target Validation Segment Value (US$ Mn), By Region 2022 to 2032

TABLE 11 Global Target Validation Segment Market Share, By Region 2015 to 2021

TABLE 12 Global Target Validation Segment Market Share, By Region 2022 to 2032

TABLE 13 Global Target Validation Segment Y-o-Y, By Region 2022 to 2032

TABLE 14 Global Hit-To-Lead Identification Segment Value (US$ Mn), By Region 2015 to 2021

TABLE 15 Global Hit-To-Lead Identification Segment Value (US$ Mn), By Region 2022 to 2032

TABLE 16 Global Hit-To-Lead Identification Segment Market Share, By Region 2015 to 2021

TABLE 17 Global Hit-To-Lead Identification Segment Market Share, By Region 2022 to 2032

TABLE 18 Global Hit-To-Lead Identification Segment Y-o-Y, By Region 2022 to 2032

TABLE 19 Global Lead Optimization Segment Value (US$ Mn), By Region 2015 to 2021

TABLE 20 Global Lead Optimization Segment Value (US$ Mn), By Region 2022 to 2032

TABLE 21 Global Lead Optimization Segment Market Share, By Region 2015 to 2021

TABLE 22 Global Lead Optimization Segment Market Share, By Region 2022 to 2032

TABLE 23 Global Lead Optimization Segment Y-o-Y, By Region 2022 to 2032

TABLE 24 Global Candidate Validation Segment Value (US$ Mn), By Region 2015 to 2021

TABLE 25 Global Candidate Validation Segment Value (US$ Mn), By Region 2022 to 2032

TABLE 26 Global Candidate Validation Segment Market Share, By Region 2015 to 2021

TABLE 27 Global Candidate Validation Segment Market Share, By Region 2022 to 2032

TABLE 28 Global Candidate Validation Segment Y-o-Y, By Region 2022 to 2032

TABLE 29 Global Medicinal Chemistry Segment Value (US$ Mn), By Region 2015 to 2021

TABLE 30 Global Medicinal Chemistry Segment Value (US$ Mn), By Region 2022 to 2032

TABLE 31 Global Medicinal Chemistry Segment Market Share, By Region 2015 to 2021

TABLE 32 Global Medicinal Chemistry Segment Market Share, By Region 2022 to 2032

TABLE 33 Global Medicinal Chemistry Segment Y-o-Y, By Region 2022 to 2032

TABLE 34 Global Biology Services Segment Value (US$ Mn), By Region 2015 to 2021

TABLE 35 Global Biology Services Segment Value (US$ Mn), By Region 2022 to 2032

TABLE 36 Global Biology Services Segment Market Share, By Region 2015 to 2021

TABLE 37 Global Biology Services Segment Market Share, By Region 2022 to 2032

TABLE 38 Global Biology Services Segment Y-o-Y, By Region 2022 to 2032

TABLE 39 Global Drug Metabolism and Pharmacokinetics Segment Value (US$ Mn), By Region 2015 to 2021

TABLE 40 Global Drug Metabolism and Pharmacokinetics Segment Value (US$ Mn), By Region 2022 to 2032

TABLE 41 Global Drug Metabolism and Pharmacokinetics Segment Market Share, By Region 2015 to 2021

TABLE 42 Global Drug Metabolism and Pharmacokinetics Segment Market Share, By Region 2022 to 2032

TABLE 43 Global Drug Metabolism and Pharmacokinetics Segment Y-o-Y, By Region 2022 to 2032

TABLE 44 Global Small Molecules Segment Value (US$ Mn), By Region 2015 to 2021

TABLE 45 Global Small Molecules Segment Value (US$ Mn), By Region 2022 to 2032

TABLE 46 Global Small Molecules Segment Market Share, By Region 2015 to 2021

TABLE 47 Global Small Molecules Segment Market Share, By Region 2022 to 2032

TABLE 48 Global Small Molecules Segment Y-o-Y, By Region 2022 to 2032

TABLE 49 Global Biologics Segment Value (US$ Mn), By Region 2015 to 2021

TABLE 50 Global Biologics Segment Value (US$ Mn), By Region 2022 to 2032

TABLE 51 Global Biologics Segment Market Share, By Region 2015 to 2021

TABLE 52 Global Biologics Segment Market Share, By Region 2022 to 2032

TABLE 53 Global Biologics Segment Y-o-Y, By Region 2022 to 2032

TABLE 54 Global Oncology Segment Value (US$ Mn), By Region 2015 to 2021

TABLE 55 Global Oncology Segment Value (US$ Mn), By Region 2022 to 2032

TABLE 56 Global Oncology Segment Market Share, By Region 2015 to 2021

TABLE 57 Global Oncology Segment Market Share, By Region 2022 to 2032

TABLE 58 Global Oncology Segment Y-o-Y, By Region 2022 to 2032

TABLE 59 Global Neurology Segment Value (US$ Mn), By Region 2015 to 2021

TABLE 60 Global Neurology Segment Value (US$ Mn), By Region 2022 to 2032

TABLE 61 Global Neurology Segment Market Share, By Region 2015 to 2021

TABLE 62 Global Neurology Segment Market Share, By Region 2022 to 2032

TABLE 63 Global Neurology Segment Y-o-Y, By Region 2022 to 2032

TABLE 64 Global Cardiovascular Diseases Segment Value (US$ Mn), By Region 2015 to 2021

TABLE 65 Global Cardiovascular Diseases Segment Value (US$ Mn), By Region 2022 to 2032

TABLE 66 Global Cardiovascular Diseases Segment Market Share, By Region 2015 to 2021

TABLE 67 Global Cardiovascular Diseases Segment Market Share, By Region 2022 to 2032

TABLE 68 Global Cardiovascular Diseases Segment Y-o-Y, By Region 2022 to 2032

TABLE 69 Global Respiratory Diseases Segment Value (US$ Mn), By Region 2015 to 2021

TABLE 70 Global Respiratory Diseases Segment Value (US$ Mn), By Region 2022 to 2032

TABLE 71 Global Respiratory Diseases Segment Market Share, By Region 2015 to 2021

TABLE 72 Global Respiratory Diseases Segment Market Share, By Region 2022 to 2032

TABLE 73 Global Respiratory Diseases Segment Y-o-Y, By Region 2022 to 2032

TABLE 74 Global Diabetes Segment Value (US$ Mn), By Region 2015 to 2021

TABLE 75 Global Diabetes Segment Value (US$ Mn), By Region 2022 to 2032

TABLE 76 Global Diabetes Segment Market Share, By Region 2015 to 2021

TABLE 77 Global Diabetes Segment Market Share, By Region 2022 to 2032

TABLE 78 Global Diabetes Segment Y-o-Y, By Region 2022 to 2032

TABLE 79 Global Other Therapeutic Areas Segment Value (US$ Mn), By Region 2015 to 2021

TABLE 80 Global Other Therapeutic Areas Segment Value (US$ Mn), By Region 2022 to 2032

TABLE 81 Global Other Therapeutic Areas Segment Market Share, By Region 2015 to 2021

TABLE 82 Global Other Therapeutic Areas Segment Market Share, By Region 2022 to 2032

TABLE 83 Global Other Therapeutic Areas Segment Y-o-Y, By Region 2022 to 2032

TABLE 84 North America Current Expenditure on Health, (% of GDP), by Country, 2022 to 2032

TABLE 85 North America Per Capita Health Expenditure (US$ PPP), by Country, 2022 to 2032

TABLE 86 North America Per Capita Healthcare Expenditure Y-o-Y Growth (in Real terms %), by Country, 2022 to 2032

TABLE 87 North America Out-of-Pocket Healthcare Expenditure, % of Healthcare Expenditure, by Country, 2022 to 2032

TABLE 88 North America Per Capita Healthcare Expenditure (at Current Price, in US$), by Country, 2022 to 2032

TABLE 89 North America Market Value (US$ Mn), By Country 2015 to 2021

TABLE 90 North America Market Value (US$ Mn), By Country 2022 to 2032

TABLE 91 North America Market Value (US$ Mn), By Process 2015 to 2021

TABLE 92 North America Market Value (US$ Mn), By Process 2022 to 2032

TABLE 93 North America Market Value (US$ Mn), By Type 2015 to 2021

TABLE 94 North America Market Value (US$ Mn), By Type 2022 to 2032

TABLE 95 North America Market Value (US$ Mn), By Drug Type 2015 to 2021

TABLE 96 North America Market Value (US$ Mn), By Drug Type 2022 to 2032

TABLE 97 North America Market Value (US$ Mn), By Therapeutic Area 2015 to 2021

TABLE 98 North America Market Value (US$ Mn), By Therapeutic Area 2022 to 2032

TABLE 99 Latin America Current Expenditure on Health, (% of GDP), by Country, 2022 to 2032

TABLE 100 Latin America Per Capita Health Expenditure (US$ PPP), by Country, 2022 to 2032

TABLE 101 Latin America Per Capita Healthcare Expenditure Y-o-Y Growth (in Real terms %), by Country, 2022 to 2032

TABLE 102 Latin America Out-of-Pocket Healthcare Expenditure, % of Healthcare Expenditure, by Country, 2022 to 2032

TABLE 103 Latin America Per Capita Healthcare Expenditure (at Current Price, in US$), by Country, 2022 to 2032

TABLE 104 Latin America Market Value (US$ Mn), By Country 2015 to 2021

TABLE 105 Latin America Market Value (US$ Mn), By Country 2022 to 2032

TABLE 106 Latin America Market Value (US$ Mn), By Process 2015 to 2021

TABLE 107 Latin America Market Value (US$ Mn), By Process 2022 to 2032

TABLE 108 Latin America Market Value (US$ Mn), By Type 2015 to 2021

TABLE 109 Latin America Market Value (US$ Mn), By Type 2022 to 2032

TABLE 110 Latin America Market Value (US$ Mn), By Drug Type 2015 to 2021

TABLE 111 Latin America Market Value (US$ Mn), By Drug Type 2022 to 2032

TABLE 112 Latin America Market Value (US$ Mn), By Therapeutic Area 2015 to 2021

TABLE 113 Latin America Market Value (US$ Mn), By Therapeutic Area 2022 to 2032

TABLE 114 Europe Current Expenditure on Health, (% of GDP), by Country, 2022 to 2032

TABLE 115 Europe Per Capita Health Expenditure (US$ PPP), by Country, 2022 to 2032

TABLE 116 Europe Per Capita Healthcare Expenditure Y-o-Y Growth (in Real terms %), by Country, 2022 to 2032

TABLE 117 Europe Out-of-Pocket Healthcare Expenditure, % of Healthcare Expenditure, by Country, 2022 to 2032

TABLE 118 Europe Per Capita Healthcare Expenditure (at Current Price, in US$), by Country, 2022 to 2032

TABLE 119 Europe Market Value (US$ Mn), By Country 2015 to 2021

TABLE 120 Europe Market Value (US$ Mn), By Country 2022 to 2032

TABLE 121 Europe Market Value (US$ Mn), By Process 2015 to 2021

TABLE 122 Europe Market Value (US$ Mn), By Process 2022 to 2032

TABLE 123 Europe Market Value (US$ Mn), By Type 2015 to 2021

TABLE 124 Europe Market Value (US$ Mn), By Type 2022 to 2032

TABLE 125 Europe Market Value (US$ Mn), By Drug Type 2015 to 2021

TABLE 126 Europe Market Value (US$ Mn), By Drug Type 2022 to 2032

TABLE 127 Europe Market Value (US$ Mn), By Therapeutic Area 2015 to 2021

TABLE 128 Europe Market Value (US$ Mn), By Therapeutic Area 2022 to 2032

TABLE 129 Japan Current Expenditure on Health, (% of GDP), by Country, 2022 to 2032

TABLE 130 Japan Per Capita Health Expenditure (US$ PPP), by Country, 2022 to 2032

TABLE 131 Japan Per Capita Healthcare Expenditure Y-o-Y Growth (in Real terms %), by Country, 2022 to 2032

TABLE 132 Japan Out-of-Pocket Healthcare Expenditure, % of Healthcare Expenditure, by Country, 2022 to 2032

TABLE 133 Japan Per Capita Healthcare Expenditure (at Current Price, in US$), by Country, 2022 to 2032

TABLE 134 Japan Market Value (US$ Mn), By Country 2015 to 2021

TABLE 135 Japan Market Value (US$ Mn), By Country 2022 to 2032

TABLE 136 Japan Market Value (US$ Mn), By Process 2015 to 2021

TABLE 137 Japan Market Value (US$ Mn), By Process 2022 to 2032

TABLE 138 Japan Market Value (US$ Mn), By Type 2015 to 2021

TABLE 139 Japan Market Value (US$ Mn), By Type 2022 to 2032

TABLE 140 Japan Market Value (US$ Mn), By Drug Type 2015 to 2021

TABLE 141 Japan Market Value (US$ Mn), By Drug Type 2022 to 2032

TABLE 142 Japan Market Value (US$ Mn), By Therapeutic Area 2015 to 2021

TABLE 143 Japan Market Value (US$ Mn), By Therapeutic Area 2022 to 2032

TABLE 144 APEJ Current Expenditure on Health, (% of GDP), by Country, 2022 to 2032

TABLE 145 APEJ Per Capita Health Expenditure (US$ PPP), by Country, 2022 to 2032

TABLE 146 APEJ Per Capita Healthcare Expenditure Y-o-Y Growth (in Real terms %), by Country, 2022 to 2032

TABLE 147 APEJ Out-of-Pocket Healthcare Expenditure, % of Healthcare Expenditure, by Country, 2022 to 2032

TABLE 148 APEJ Per Capita Healthcare Expenditure (at Current Price, in US$), by Country, 2022 to 2032

TABLE 149 APEJ Market Value (US$ Mn), By Country 2015 to 2021

TABLE 150 APEJ Market Value (US$ Mn), By Country 2022 to 2032

TABLE 151 APEJ Market Value (US$ Mn), By Process 2015 to 2021

TABLE 152 APEJ Market Value (US$ Mn), By Process 2022 to 2032

TABLE 153 APEJ Market Value (US$ Mn), By Type 2015 to 2021

TABLE 154 APEJ Market Value (US$ Mn), By Type 2022 to 2032

TABLE 155 APEJ Market Value (US$ Mn), By Drug Type 2015 to 2021

TABLE 156 APEJ Market Value (US$ Mn), By Drug Type 2022 to 2032

TABLE 157 APEJ Market Value (US$ Mn), By Therapeutic Area 2015 to 2021

TABLE 158 APEJ Market Value (US$ Mn), By Therapeutic Area 2022 to 2032

TABLE 159 MEA Current Expenditure on Health, (% of GDP), by Country, 2022 to 2032

TABLE 160 MEA Per Capita Health Expenditure (US$ PPP), by Country, 2022 to 2032

TABLE 161 MEA Per Capita Healthcare Expenditure Y-o-Y Growth (in Real terms %), by Country, 2022 to 2032

TABLE 162 MEA Out-of-Pocket Healthcare Expenditure, % of Healthcare Expenditure, by Country, 2022 to 2032

TABLE 163 MEA Per Capita Healthcare Expenditure (at Current Price, in US$), by Country, 2022 to 2032

TABLE 164 MEA Market Value (US$ Mn), By Country 2015 to 2021

TABLE 165 MEA Market Value (US$ Mn), By Country 2022 to 2032

TABLE 166 MEA Market Value (US$ Mn), By Process 2015 to 2021

TABLE 167 MEA Market Value (US$ Mn), By Process 2022 to 2032

TABLE 168 MEA Market Value (US$ Mn), By Type 2015 to 2021

TABLE 169 MEA Market Value (US$ Mn), By Type 2022 to 2032

TABLE 170 MEA Market Value (US$ Mn), By Drug Type 2015 to 2021

TABLE 171 MEA Market Value (US$ Mn), By Drug Type 2022 to 2032

TABLE 172 MEA Market Value (US$ Mn), By Therapeutic Area 2015 to 2021

TABLE 173 MEA Market Value (US$ Mn), By Therapeutic Area 2022 to 2032

List Of Figures

FIG. 1 Global Market Value (US$ Mn), 2015 to 2021

FIG. 2 Global Market Value (US$ Mn) Forecast, 2022 to 2032

FIG. 3 Global Market Value (US$ Mn) and Y-o-Y, 2022 to 2032

FIG. 4 Global Target Selection Segment Market Value (US$ Mn) By Region, 2015 to 2021

FIG. 5 Global Target Selection Segment Market Value (US$ Mn) By Region, 2022 to 2032

FIG. 6 Global Target Selection Segment Y-o-Y Growth Rate, By Region, 2022 to 2032

FIG. 7 Global Target Validation Segment Market Value (US$ Mn) By Region, 2015 to 2021

FIG. 8 Global Target Validation Segment Market Value (US$ Mn) By Region, 2022 to 2032

FIG. 9 Global Target Validation Segment Y-o-Y Growth Rate, By Region, 2022 to 2032

FIG. 10 Global Hit-To-Lead Identification Segment Market Value (US$ Mn) By Region, 2015 to 2021

FIG. 11 Global Hit-To-Lead Identification Segment Market Value (US$ Mn) By Region, 2022 to 2032

FIG. 12 Global Hit-To-Lead Identification Segment Y-o-Y Growth Rate, By Region, 2022 to 2032

FIG. 13 Global Lead Optimization Segment Market Value (US$ Mn) By Region, 2015 to 2021

FIG. 14 Global Lead Optimization Segment Market Value (US$ Mn) By Region, 2022 to 2032

FIG. 15 Global Lead Optimization Segment Y-o-Y Growth Rate, By Region, 2022 to 2032

FIG. 16 Global Candidate Validation Segment Market Value (US$ Mn) By Region, 2015 to 2021

FIG. 17 Global Candidate Validation Segment Market Value (US$ Mn) By Region, 2022 to 2032

FIG. 18 Global Candidate Validation Segment Y-o-Y Growth Rate, By Region, 2022 to 2032

FIG. 19 Global Medicinal Chemistry Segment Market Value (US$ Mn) By Region, 2015 to 2021

FIG. 20 Global Medicinal Chemistry Segment Market Value (US$ Mn) By Region, 2022 to 2032

FIG. 21 Global Medicinal Chemistry Segment Y-o-Y Growth Rate, By Region, 2022 to 2032

FIG. 22 Global Biology Services Segment Market Value (US$ Mn) By Region, 2015 to 2021

FIG. 23 Global Biology Services Segment Market Value (US$ Mn) By Region, 2022 to 2032

FIG. 24 Global Biology Services Segment Y-o-Y Growth Rate, By Region, 2022 to 2032

FIG. 25 Global Drug Metabolism and Pharmacokinetics Segment Market Value (US$ Mn) By Region, 2015 to 2021

FIG. 26 Global Drug Metabolism and Pharmacokinetics Segment Market Value (US$ Mn) By Region, 2022 to 2032

FIG. 27 Global Drug Metabolism and Pharmacokinetics Segment Y-o-Y Growth Rate, By Region, 2022 to 2032

FIG. 28 Global Small Molecules Segment Market Value (US$ Mn) By Region, 2015 to 2021

FIG. 29 Global Small Molecules Segment Market Value (US$ Mn) By Region, 2022 to 2032

FIG. 30 Global Small Molecules Segment Y-o-Y Growth Rate, By Region, 2022 to 2032

FIG. 31 Global Biologics Segment Market Value (US$ Mn) By Region, 2015 to 2021

FIG. 32 Global Biologics Segment Market Value (US$ Mn) By Region, 2022 to 2032

FIG. 33 Global Biologics Segment Y-o-Y Growth Rate, By Region, 2022 to 2032

FIG. 34 Global Oncology Segment Market Value (US$ Mn) By Region, 2015 to 2021

FIG. 35 Global Oncology Segment Market Value (US$ Mn) By Region, 2022 to 2032

FIG. 36 Global Oncology Segment Y-o-Y Growth Rate, By Region, 2022 to 2032

FIG. 37 Global Neurology Segment Market Value (US$ Mn) By Region, 2015 to 2021

FIG. 38 Global Neurology Segment Market Value (US$ Mn) By Region, 2022 to 2032

FIG. 39 Global Neurology Segment Y-o-Y Growth Rate, By Region, 2022 to 2032

FIG. 40 Global Cardiovascular Diseases Segment Market Value (US$ Mn) By Region, 2015 to 2021

FIG. 41 Global Cardiovascular Diseases Segment Market Value (US$ Mn) By Region, 2022 to 2032

FIG. 42 Global Cardiovascular Diseases Segment Y-o-Y Growth Rate, By Region, 2022 to 2032

FIG. 43 Global Respiratory Diseases Segment Market Value (US$ Mn) By Region, 2015 to 2021

FIG. 44 Global Respiratory Diseases Segment Market Value (US$ Mn) By Region, 2022 to 2032

FIG. 45 Global Respiratory Diseases Segment Y-o-Y Growth Rate, By Region, 2022 to 2032

FIG. 46 Global Diabetes Segment Market Value (US$ Mn) By Region, 2015 to 2021

FIG. 47 Global Diabetes Segment Market Value (US$ Mn) By Region, 2022 to 2032

FIG. 48 Global Diabetes Segment Y-o-Y Growth Rate, By Region, 2022 to 2032

FIG. 49 Global Other Therapeutic Areas Segment Market Value (US$ Mn) By Region, 2015 to 2021

FIG. 50 Global Other Therapeutic Areas Segment Market Value (US$ Mn) By Region, 2022 to 2032

FIG. 51 Global Other Therapeutic Areas Segment Y-o-Y Growth Rate, By Region, 2022 to 2032

FIG. 52 North America Market Value (US$ Mn), By Country 2015 to 2021

FIG. 53 North America Market Value (US$ Mn), By Country 2022 to 2032

FIG. 54 North America Market Value (US$ Mn), By Process 2015 to 2021

FIG. 55 North America Market Value (US$ Mn), By Process 2022 to 2032

FIG. 56 North America Market Value (US$ Mn), By Type 2015 to 2021

FIG. 57 North America Market Value (US$ Mn), By Type 2022 to 2032

FIG. 58 North America Market Value (US$ Mn), By Drug Type 2015 to 2021

FIG. 59 North America Market Value (US$ Mn), By Drug Type 2022 to 2032

FIG. 60 North America Market Value (US$ Mn), By Therapeutic Area 2015 to 2021

FIG. 61 North America Market Value (US$ Mn), By Therapeutic Area 2022 to 2032

FIG. 62 Latin America Market Value (US$ Mn), By Country 2015 to 2021

FIG. 63 Latin America Market Value (US$ Mn), By Country 2022 to 2032

FIG. 64 Latin America Market Value (US$ Mn), By Process 2015 to 2021

FIG. 65 Latin America Market Value (US$ Mn), By Process 2022 to 2032

FIG. 66 Latin America Market Value (US$ Mn), By Type 2015 to 2021

FIG. 67 Latin America Market Value (US$ Mn), By Type 2022 to 2032

FIG. 68 Latin America Market Value (US$ Mn), By Drug Type 2015 to 2021

FIG. 69 Latin America Market Value (US$ Mn), By Drug Type 2022 to 2032

FIG. 70 Latin America Market Value (US$ Mn), By Therapeutic Area 2015 to 2021

FIG. 71 Latin America Market Value (US$ Mn), By Therapeutic Area 2022 to 2032

FIG. 72 Europe Market Value (US$ Mn), By Country 2015 to 2021

FIG. 73 Europe Market Value (US$ Mn), By Country 2022 to 2032

FIG. 74 Europe Market Value (US$ Mn), By Process 2015 to 2021

FIG. 75 Europe Market Value (US$ Mn), By Process 2022 to 2032

FIG. 76 Europe Market Value (US$ Mn), By Type 2015 to 2021

FIG. 77 Europe Market Value (US$ Mn), By Type 2022 to 2032

FIG. 78 Europe Market Value (US$ Mn), By Drug Type 2015 to 2021

FIG. 79 Europe Market Value (US$ Mn), By Drug Type 2022 to 2032

FIG. 80 Europe Market Value (US$ Mn), By Therapeutic Area 2015 to 2021

FIG. 81 Europe Market Value (US$ Mn), By Therapeutic Area 2022 to 2032

FIG. 82 Japan Market Value (US$ Mn), By Country 2015 to 2021

FIG. 83 Japan Market Value (US$ Mn), By Country 2022 to 2032

FIG. 84 Japan Market Value (US$ Mn), By Process 2015 to 2021

FIG. 85 Japan Market Value (US$ Mn), By Process 2022 to 2032

FIG. 86 Japan Market Value (US$ Mn), By Type 2015 to 2021

FIG. 87 Japan Market Value (US$ Mn), By Type 2022 to 2032

FIG. 88 Japan Market Value (US$ Mn), By Drug Type 2015 to 2021

FIG. 89 Japan Market Value (US$ Mn), By Drug Type 2022 to 2032

FIG. 90 Japan Market Value (US$ Mn), By Therapeutic Area 2015 to 2021

FIG. 91 Japan Market Value (US$ Mn), By Therapeutic Area 2022 to 2032

FIG. 92 APEJ Market Value (US$ Mn), By Country 2015 to 2021

FIG. 93 APEJ Market Value (US$ Mn), By Country 2022 to 2032

FIG. 94 APEJ Market Value (US$ Mn), By Process 2015 to 2021

FIG. 95 APEJ Market Value (US$ Mn), By Process 2022 to 2032

FIG. 96 APEJ Market Value (US$ Mn), By Type 2015 to 2021

FIG. 97 APEJ Market Value (US$ Mn), By Type 2022 to 2032

FIG. 98 APEJ Market Value (US$ Mn), By Drug Type 2015 to 2021

FIG. 99 APEJ Market Value (US$ Mn), By Drug Type 2022 to 2032

FIG. 100 APEJ Market Value (US$ Mn), By Therapeutic Area 2015 to 2021

FIG. 101 APEJ Market Value (US$ Mn), By Therapeutic Area 2022 to 2032

FIG. 102 MEA Market Value (US$ Mn), By Country 2015 to 2021

FIG. 103 MEA Market Value (US$ Mn), By Country 2022 to 2032

FIG. 104 MEA Market Value (US$ Mn), By Process 2015 to 2021

FIG. 105 MEA Market Value (US$ Mn), By Process 2022 to 2032

FIG. 106 MEA Market Value (US$ Mn), By Type 2015 to 2021

FIG. 107 MEA Market Value (US$ Mn), By Type 2022 to 2032

FIG. 108 MEA Market Value (US$ Mn), By Drug Type 2015 to 2021

FIG. 109 MEA Market Value (US$ Mn), By Drug Type 2022 to 2032

FIG. 110 MEA Market Value (US$ Mn), By Therapeutic Area 2015 to 2021

FIG. 111 MEA Market Value (US$ Mn), By Therapeutic Area 2022 to 2032

Drug Discovery Services Market

Free Sample Buy Report Now

Copyright © Fact.MR All Rights Reserved

An initiative of Eminent Research and Advisory Services